Health Canada
NOTICE
Implementation of International Council for Harmonisation (ICH) Q12 - Technical and regulatory considerations for pharmaceutical product lifecycle management: Notice
Published: 10/17/2025Detected: 3/22/2026
Summary preview
Implements ICH Q12 by outlining technical and regulatory considerations to support a more structured lifecycle approach for pharmaceutical product changes in Canada.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#ICH Q12
#pharmaceutical product lifecycle management
#post-approval changes
#regulatory considerations
#change control
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/2/2026
- Advisory Committee: National Pharmacare Committee of Experts10/2/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/2/2026
- Advisory Committee: Expert Task Force on Substance Use10/2/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/2/2026